We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Brush Biopsy Test Detects Oral Cancer without Surgery

By LabMedica International staff writers
Posted on 18 Jan 2024
Print article
Image: The cancer detection kit requires less than a minute of gentle brushing to collect a sample (Photo courtesy of Lucia Adami)
Image: The cancer detection kit requires less than a minute of gentle brushing to collect a sample (Photo courtesy of Lucia Adami)

Oral squamous cell carcinoma, the most common type of oral cancer and globally the ninth most prevalent cancer, currently relies on surgical biopsies for diagnosis. This additional referral step poses the risk of losing patients who may not return for follow-up until the cancer has progressed to advanced, more challenging stages. Additionally, surgical biopsies can be problematic as they often collect a mix of cell types, complicating the analysis, and creating the risk of spreading cancerous cells to other parts of the mouth. General blood tests looking for cancer's genetic signals also have limitations, as they do not specify the tumor’s location, preventing quick initiation of treatment after detection. Now, a new test that allows dentists to screen for oral squamous cell carcinoma with a simple brush could early detection of oral cancer without surgery.

The diagnostic kit, created by researchers at the University of Illinois Chicago (Urbana, IL, USA), employs a small brush to gather cells from potential cancerous lesions in the mouth. It operates by detecting tiny segments of genetic material, known as microRNA, which regulate gene expression. Studies conducted by the researchers found a unique expression signature of 40 microRNA sequences that can accurately differentiate between a tumor and normal tissue with more than 90% accuracy. Significantly, their test also successfully works with epithelial cells, the outermost layer in the patient’s mouth. These cells can be quickly and painlessly collected in under a minute by a dentist or nurse using gentle brushing. After collection, the brush is placed in a solution tube and sent to a lab for microRNA analysis, with results being available within days using the current test version.

The brush biopsy test offers several advantages, including specific targeting of the tissue site. The researchers anticipate that this new test will simplify screening, especially in populations that lack regular dental care or are more prone to oral squamous cell carcinoma. For instance, Black men, who experience significantly lower survival rates with this disease compared to other racial groups, could benefit greatly. The potential for using this technology in non-clinical settings opens up opportunities for earlier cancer detection in high-risk groups. Additionally, this approach could eventually help diagnose other oral diseases, each identified by unique microRNA signatures.

“We were the first to observe that brush biopsy samples actually work quite well when you use microRNA,” said Guy Adami of the UIC College of Dentistry. “All you need is a good light and the brushes.”

“There are 600 different diseases that occur in the mouth, and a number of these have already been characterized with microRNAs,” added Dr. Joel Schwartz of the UIC College of Dentistry. “We could use the same approach and really have a profound impact on these kinds of disease.”

Related Links:
University of Illinois Chicago

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Pathology

view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more

Industry

view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.